Cancer Screening

Individuals with transportation insecurity appeared 41% less likely to undergo breast cancer screening than those without transportation difficulties, according to results of a cohort study.

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings published in The Lancet Diabetes & Endocrinology.

Among populations with low adherence to colorectal cancer screening, annual fecal immunochemical testing was the cheapest and most effective noninvasive screening method, according to a study published in JAMA Network Open.

AI-supported breast cancer screening increased early-stage cancer detection while reducing radiologists’ workload without increasing false positives, but more research is needed before clinical implementation, researchers reported.

Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep Advances.

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received testing had HPV persistence or progression.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with an individual’s age, sex, comorbidity status and screening history, according to results of an economic evaluation.

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults undergoing screening for lung cancer, the results of a randomized clinical trial showed.

Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, with researchers suggesting the recommended 10-year rescreening interval may be extended for this population.